by Chris Musillo

The Department of State has just issued the June 2018 Visa Bulletin. This is the ninth Visa Bulletin of Fiscal Year 2018. This blog post analyzes this month's Visa Bulletin.

June 2018 Visa Bulletin

Table A: Final Action Dates -- Applications with these dates may be approved for their Green Card (Permanent Residency card) or Immigrant Visa appointment.


EB

Class
All Other
CHINA
INDIA
MEXICO
PHIL'PNES
EB-1
C
01JAN12
01JAN12
C
C
EB-2
C
01SEP14
26DEC08
C
C
EB-3
C
01JUN15
01MAY08
C
01JAN17

Table B: Dates for Filing -- The DOS may work on applications with these dates. But the Visa cannot be approved until the date is current per Table A.


EB


Class
All Other
CHINA
INDIA
MEXICO
PHIL'PNES
EB-1
C
C
C
C
C
EB-2
C
01FEB15
01APR09
C
C
EB-3
C
01JAN16
01SEP08
C
01JUL17
MU Law Analysis (all references are to Table A unless noted)


All Other: The EB-2 has been current for many years. The EB-3 is also current and is expected to remain current for the foreseeable future.


China (mainland-born): As with all categories this month, the movements were nonexistent. It would not surprise MU if the Chinese numbers did not move for the remainder of the fiscal year. China EB-2 is a better bet to progress than EB-3, although it remains doubtful that EB-2 progresses ahead of EB-3.

India: There is a similar story with India as with China. No progress, outside of a minor 4 day movement in EB-3. We would not be surprised to see minor movements in these categories before the end of the fiscal year.

Mexico: Mirrors All Other in analysis.

Philippines: Phils EB-3 stayed the same, which is not surprising considering the enormous progressions of the last few years. The Phils EB-3 number will probably continue to only move negligible, reflecting the large numbers of Philippine RN EB-3 petitions that were filed in 2016-2018. There is a chance of a small progression in the next few VBs.

_______________
Please read the Musillo Unkenholt Healthcare and Immigration Law Blog at www.musillo.com and www.ilw.com. You can also visit us on Facebook, Twitter, and LinknedIn.